| Literature DB >> 10431146 |
.
Abstract
Assay miniaturization applicable across a wide range of target classes, along with automation and process integration, are well-recognized goals for ultra-high-throughput screening on an industrial scale. This report summarizes the implementation of fluorescence resonance energy transfer (FRET)-based biochemical and cell-based assays in 3456-well NanoWelltrade mark assay plates using key components of Aurora's ultra-high-throughput screening system.Year: 1999 PMID: 10431146 DOI: 10.1016/s1359-6446(99)01377-x
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851